Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02252 MEDBOT-B
RT Nominal down8.170 -0.980 (-10.710%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others367,017-25.339%491,576361,00038,71014,443
Land & other Lease Assets0--0000
Intangible Assets11,01929.104%8,5354,5562,047337
Interests in Asso. & JCEs148,282-15.342%175,154123,53785,4300
Other Non-current Assets107,541-31.080%156,038208,56563,1177,328

633,859-23.751%831,303697,658189,30422,108
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories229,505-8.373%250,478109,88100
Trade Receivables4,969--08700
Cash & Bank Balances507,711-32.121%747,9621,940,8251,497,32654,708
Other Current Assets51,863-48.334%100,38243,43317,7241,619
Assets Held for Sale0--0000

794,048-27.736%1,098,8222,094,2261,515,05056,327
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables74,251-40.382%124,54483,60128,34512,132
S-T Debt & Leases423,236626.985%58,21852,8637,2885,571
Other Current Liabilities187,78931.734%142,55298,005193,27523,596
Liab asso w/ Assets Held for Sale0--0000

685,276110.651%325,314234,469228,90841,299
Net Current Assets108,772-85.938%773,5081,859,7571,286,14215,028
Total Assets Less Current Liabilities742,631-53.725%1,604,8112,557,4151,475,44637,136
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases172,2076.477%161,732151,81311,5936,347
Other Non-current Liabilities68,66995.077%35,20115,45022,4014,378

240,87622.314%196,933167,26333,99410,725
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital958,5940.000%958,594958,594900,00035,077
  Reserves(439,114)--459,0641,434,548542,856(8,666)
  Others0--0000
Shareholders' Funds519,480-63.356%1,417,6582,393,1421,442,85626,411
Non-controlling Interests(17,725)81.237%(9,780)(2,990)(1,404)0
Others0--0000

501,755-64.361%1,407,8782,390,1521,441,45226,411
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments23,006-81.973%127,62290,220120,217382
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 22/11/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -277,161,000
%Change-48.580%
EPS / (LPS)RMB -0.290
NBV Per Share (¥)RMB 0.287
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.